Press release
Oncolytic Virus Market Report 2019 |By Global Market Outlook, Research, Trends and Forecast to 2025 | Key Players Included: Pfizer, Roche, Cold Genesys, Genelux, Latima, Neotropix
Oncolytic Virus Market
The study covers significant data which makes the research document a handy resource for managers, industry executives and other key people get ready-to-access and self-analyzed study along with charts, graphs and tables to help understand market trends, drivers and market challenges.
Request for PDF Sample of this Report@ https://supplydemandmarketresearch.com/home/contact/83849?ref=Sample-and-Brochure&toccode=SDMRPH83849&utm_source=AS
The various contributors involved in the value chain of Oncolytic Virus include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Oncolytic Virus include
• Merck
• Otsuka Pharmaceutical Co
• Pfizer
• Roche
• Cold Genesys
• Genelux
• Latima
• Neotropix
• Shanghai Sunway Biotech
• SillaJen
• Takara Bio
• Theravir
Market Size Split by Type
• HSV-based Oncolytic Viruses
• Adenoviruses-based Oncolytic Viruses
• Vaccinia Virus-based Oncolytic Viruses
• Vesicular Stomatitis Virus-based Oncolytic Viruses
• Newcastle Disease Virus-based Oncolytic Viruses
Market Size Split by Application
• Pharmaceutical
• Health Care
• Commerical
Request for Discount on this report@ https://supplydemandmarketresearch.com/home/contact/83849?ref=Discount&toccode=SDMRPH83849&utm_source=AS
The study objectives of this report are:
• To study and analyze the global Oncolytic Virus market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
• To understand the structure of Oncolytic Virus market by identifying its various subsegments.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• Focuses on the key global Oncolytic Virus manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Oncolytic Virus with respect to individual growth trends, future prospects, and their contribution to the total market.
• To project the value and volume of Oncolytic Virus submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.
About Supply Demand Market Research(SDMR)
We have a strong network of high powered and experienced global consultants who have about 10+ years of experience in the specific industry to deliver quality research and analysis.
Having such an experienced network, our services not only cater to the client who wants the basic reference of market numbers and related high growth areas in the demand side, but also we provide detailed and granular information using which the client can definitely plan the strategies with respect to both supply and demand side.
Canada Office:
302-20 Misssisauga Valley Blvd, Missisauga, L5A 3S1, Toronto
Contact Us
info@supplydemandmarketresearch.com
https://supplydemandmarketresearch.com
Global Contact: +1-276-477-5910
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncolytic Virus Market Report 2019 |By Global Market Outlook, Research, Trends and Forecast to 2025 | Key Players Included: Pfizer, Roche, Cold Genesys, Genelux, Latima, Neotropix here
News-ID: 1675395 • Views: …
More Releases from Supply Demand Market Research
Global Artificial Intelligence Infrastructure Project Intelligence Market Trends …
Artificial Intelligence is triggering one of the largest infrastructure investment cycles in modern economic history. The global AI infrastructure market, including AI data centers, accelerated computing systems, networking, power infrastructure, cooling systems, storage and supporting technologies, is expected to grow and reach USD 250 Billion by 2030. SDMR has recently published Global AI Infrastructure Project Intelligence (2026-2040). Our report is one of the world's most comprehensive databases of AI infrastructure…
AI Data Center Liquid Cooling Market & Project Pipeline Intelligence Report 2026 …
We have recently published Global AI Data Center Project Tracker & Liquid Cooling Intelligence Database (2026-2032). Our report includes intelligence database tracks 500+ existing, under-construction, and planned AI-ready data center projects across North America, Europe, the Middle East, Asia-Pacific, and Africa.
Global hyperscaler capital expenditure is on pace to reach roughly US$600-690 billion in 2026 among the five largest U.S. cloud and AI companies alone, up 45% year-on-year, with an estimated…
Japan Waste Heat Recovery System is anticipated to reach USD 2.0 billion by 2030
Japan Waste Heat Recovery System is anticipated to reach USD 2.0 billion by 2030 growing at a CARG of 6.4% from 2024-2030. Japan has formally adopted a national target of carbon neutrality by 2050 and a 46% greenhouse-gas reduction by 2030 relative to 2013 levels, as articulated in the 6th Strategic Energy Plan. This plan makes energy-efficiency improvements, including industrial waste heat utilization, an integral part of reaching these commitments.
By…
Global Green Hydrogen is anticipated to reach USD 75 Billion by 2030
The green hydrogen domain is characterized by highly specialized recovery processes and electrolyser is the major cost component, complex utility, environmental, integration, heavy dependence on clean energy sources. Given these dynamics, the success of clients' entry into this space hinges on a rigorous, data-backed Go/No-Go evaluation, supported by credible cost-expense-margin modelling, technology benchmarking, and a clear understanding of the commercial viability.
One of the important aspects of producing green hydrogen are…
More Releases for Virus
Enhancing Oncolytic Virus Efficacy with Creative Biolabs' One-Stop Vaccinia Viru …
New York, USA - May 25, 2026 - Creative Biolabs is at the forefront of advancing oncolytic virus therapy development, particularly specializing in oncolytic vaccinia virus enhancement by improving virus replication, tumor selectivity, and efficacy.
Image: https://prchoicesweb.wordpress.com/wp-content/uploads/2026/05/creative-biolabs-logo-1.jpg
What is Vaccinia Virus?
Vaccinia virus, as a well-known oncolytic virus type that has been historically used in vaccine development, particularly for smallpox, has shown immense potential in cancer immunotherapy and has become a key tool…
Zika Virus Vaccines Market 2022 | High rate of incidence of active Zika virus in …
Zika Virus Vaccines Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $18,697 million by 2022, registering a CAGR of 5.2% during the forecast period 2017-2022.Key opportunities include the need for vaccines for immunization & prevention of further spread of Zika virus infection and for treatment of Zika-linked birth defects.
Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/1817
The outbreak of Zika virus infection in Latin…
Viral Disease Diagnosis Market - Revolutionary Trends 2025 | Cytomegalovirus, De …
Global Viral Disease Diagnosis Market: Snapshot
Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.…
Viral Disease Diagnosis Market to See Huge Growth by 2025 | Measles Virus, Polio …
Global Viral Disease Diagnosis Market: Snapshot
Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.…
Virus Free Corporate Training
Interaction for learning is critical but our customers are slowly starting to realise that this doesn’t necessarily need to take place face to face. Virtual instructor led training (VILT) makes learning more accessible by removing geographical barriers. It helps improve user product adoption, knowledge and career development and eliminates the need for costly and time-consuming travel. Still, there’s often a misconception that in person training is the only type of…
Tick-borne Encephalitis Inactivated Vaccine Market Report 2018: Segmentation by …
Global Tick-borne Encephalitis Inactivated Vaccine market research report provides company profile for Pfizer Inc., Encephalitis Global, Inc., The Cochrane Collaboration, Sonic HealthPlus Pty Ltd., Superdrug Health Clinic, GlaxoSmithKline plc, Merck & Co., Inc., Baxter International Inc., London Travel Clinic and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of…
